COPE for Children With Asthma: Intervention for Children With Asthma

Completed · Not applicable

Conditions studied: Childhood Asthma, Childhood Anxiety Disorder, Childhood Depression

In brief

Children with a chronic condition are at a significantly higher risk for anxiety and depression than those without a chronic condition. Asthma is the most common childhood chronic condition. Children with asthma and co-morbid anxiety and/or depression are at risk of poor health outcomes. The purpose of this study is to evaluate the effects of a manualized cognitive behavior skills-building intervention on key physical and mental health outcomes in 8 to 12-year old children with persistent asthma and co-morbid anxiety and/or depression. The results of this study will inform a large scale randomized controlled trial to fully test this needed intervention. COPE (Creating Opportunities for Personal Empowerment), developed by Dr. Melnyk, is a manualized intervention that has been implemented with children, adolescents, and young adults. COPE is a cognitive behavior skills-building program based on cognitive behavior theory. Results from previous studies using COPE have shown consistent decreases in anxiety and depression as well as an increase in healthy lifestyle behaviors in youth with elevated anxiety and depressive symptoms in inner city and rural settings, youth with obesity, and teens experiencing chronic recurrent headaches. However, the COPE program has never been adapted and tested with children who have persistent asthma. This study proposes to test an adaptation of this evidence-based program, "COPE for Asthma," with 8 to 12-year-old children with persistent asthma and elevated anxiety and/or depressive symptoms. COPE for Asthma combines components of asthma education with cognitive behavioral skills. This novel adaptation could fill a gap in research by providing a scalable intervention for this highly vulnerable population.

Key facts

Study ID

NCT03481673

Run by

Ohio State University

People needed

33

Starts

2017-07-15

Expected to finish

2018-05-21

Last updated by the study team

2018-08-21

Who can join

Age: 8 and older, up to 12. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Children age 8-12 years enrolled in Columbus City Schools
• Diagnosis of persistent asthma requiring daily inhaled controller medication use at some point (medical condition form on file with the school/CG report)
• Have symptoms depression or anxiety per the PROMIS/SCARED measures
• Have written consent to participate provided by care giver and child assent
• The participating care giver has primary or at least equal responsibility for the day-to-day management of the child's asthma
• care givers provide written consent for their own participation
• Be able to speak, read, and write in English (care giver and child).

You may not qualify if…

• has other significant pulmonary conditions (e.g., pulmonary fibrosis, cystic fibrosis)
• currently receiving treatment from a mental health professional
• child or CG has cognitive learning disability that could interfere with the ability to comprehend the interview questions.

Where it is running

• Columbus City Schools — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.